YT, C., CA, W., JY, C., & VC, W. (2026). Safety and clinical impact of SGLT2 inhibitor in patients undergoing peritoneal dialysis: A target-trial emulation study. Clinical kidney journal, 19(6), sfag148. https://doi.org/10.1093/ckj/sfag148
Chicago Style (17th ed.) CitationYT, Chen, Wang CA, Chen JY, and Wu VC. "Safety and Clinical Impact of SGLT2 Inhibitor in Patients Undergoing Peritoneal Dialysis: A Target-trial Emulation Study." Clinical Kidney Journal 19, no. 6 (2026): sfag148. https://doi.org/10.1093/ckj/sfag148.
MLA (9th ed.) CitationYT, Chen, et al. "Safety and Clinical Impact of SGLT2 Inhibitor in Patients Undergoing Peritoneal Dialysis: A Target-trial Emulation Study." Clinical Kidney Journal, vol. 19, no. 6, 2026, p. sfag148, https://doi.org/10.1093/ckj/sfag148.